The Chemours Company research snapshot
CC AI stock analysis currently reads The Chemours Company as a deeply cyclical specialty chemical company facing PFAS litigation overhang, extremely high leverage, negative profitability, but early signs of earnings turnaround. At the July 13, 2026 data cutoff, CC closed at $17.81 with a verified market capitalization near $2.68 billion, a forward PE near 12.15x based on analyst estimates, a price-to-sales ratio of 0.46x, and an EV-to-EBITDA of 21.40x. The CC AI stock forecast is scenario-based because chemical earnings depend on TiO2 pricing, refrigerant demand, PFAS settlement costs, debt servicing ability, and the pace of the operational turnaround. This page is an informational research tool and not investment advice.
Current price
$17.81
Market cap
$2.68 billion verified market cap
AI score
48 / 100
Rating
Deeply cyclical specialty chemical company with PFAS litigation overhang, high leverage, and early turnaround signals
Trend status
Recovering from 52-week lows near $10.44, trading above the 50-day and 200-day moving averages but still well below the 52-week high near $28.67
Data cutoff (updated weekly)
July 13, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Chemours produces TiO2 pigments, refrigerants, and specialty chemicals under well-known brands including Ti-Pure, Freon, Opteon, Teflon, Viton, Krytox, and Nafion. The business is commodity-cyclical with some high-value niche products. | Medium |
| Moat | The moat is moderate in fluoroproducts via proprietary technologies and brand recognition. TiO2 has limited moat as a commodity pigment. Nafion membranes have strong IP positions in electrochemical applications. | Medium |
| Management | The current management team is executing a turnaround focused on cost reduction, debt reduction, and operational excellence. The test is whether they can navigate PFAS litigation while improving margins and generating consistent free cash flow. | Medium-low |
| Financial trend | TTM revenue was $5.82 billion with negative net income of $410 million. Q1 2026 showed modest profitability with $8 million in earnings on $1.38 billion revenue. The balance sheet is highly leveraged with total debt/equity over 2,000%. | High |
| Valuation | At $17.81, CC trades at 0.46x price-to-sales, 12.15x forward PE (based on analyst estimates), EV/EBITDA of 21.40x, and 12.46x book value. The valuation appears low on sales but high on EBITDA given the leverage. | Medium |
| Technical trend | CC recovered strongly from the $10.44 low and has a positive intermediate trend above the 50-day and 200-day moving averages, with room to run toward the $28.67 52-week high. | Medium |
| Risk level | Key risks are PFAS litigation costs, high debt leverage, TiO2 pricing cycles, refrigerant regulatory changes, and potential equity dilution. The $450 million federal PFAS settlement is one piece of a larger liability picture. | Medium-high |
| AI confidence | Descriptive confidence is medium-high for reported financial data. Forecast confidence is lower because the PFAS liability range is wide, chemical pricing is volatile, and the high debt amplifies earnings swings. | Medium data confidence |
| Investment certainty | CC is a high-risk turnaround that could work if PFAS liabilities stay manageable and chemical markets stabilize, but the leverage and litigation overhang make it a speculative position rather than a compounder. | Low |
CC AI stock forecast
The CC AI stock forecast uses the $17.81 price reference and a three-year scenario model. The wide range reflects the leverage effect of debt, chemical price cycles, and PFAS litigation uncertainty. Analyst consensus (Mizuho, JPMorgan) targets near $25, but outcomes vary significantly based on litigation, TiO2 demand, and refrigerant market conditions.
$30 to $38
More likely if PFAS liabilities are capped at manageable levels, TiO2 demand recovers with global construction and coatings, Opteon refrigerant adoption accelerates, free cash flow improves to cover debt service, and the forward PE re-rates toward 15x to 18x normalized earnings.
$18 to $25
More likely if PFAS settlement costs absorb a meaningful portion of free cash flow, TiO2 markets remain stable but do not boom, the company maintains its turnaround trajectory with modest earnings recovery, and the stock trades in line with analyst target ranges near $25.
$6 to $12
More likely if PFAS liabilities expand significantly beyond current estimates, chemical demand weakens in a recession, debt covenants come under pressure, the company faces equity dilution or liquidity stress, and the stock is re-rated toward distressed multiples.
CC AI technical analysis
CC AI technical analysis shows a stock recovering from deeply oversold levels as of the July 13, 2026 cutoff. Yahoo Finance data indicated CC at $17.81 on July 10, with a 52-week range of $10.44 to $28.67. The stock has stabilized above prior lows but still trades 38% below the 52-week high, suggesting room for mean reversion if fundamentals improve.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $17.81 | Yahoo Finance closing quote for July 10, 2026, used for market-cap and valuation checks at the July 13 data cutoff. |
| Immediate support | $15 to $16 | This zone represents the consolidation area after the rally from $10.44 and is the first line of defense for the recovery trend. |
| Deeper support | $10 to $11 | The 52-week low zone near $10.44 marks the panic low from 2025. A retest would indicate a breakdown in the turnaround thesis. |
| Near resistance | $20 to $21 | Round-number resistance near $20 with prior supply from the 2025 breakdown area. Clearing this opens the path toward analyst targets. |
| Key resistance | $25 to $29 | The 52-week high near $28.67 and analyst consensus near $25.33 form the upper resistance cluster that would confirm a full trend reversal. |
| Moving averages | Recovered above 50-day and 200-day | Price above both key moving averages is a positive technical signal. The crossover momentum supports the recovery narrative. |
| Momentum | RSI recovering from oversold | Momentum improved significantly from the 2025 lows but is not yet overbought, leaving room for further upside. |
| Volume | Average volume near 2.7 million shares | Volume provides reasonable liquidity. Watch for volume confirmation on any breakout above $20. |
| Volatility | Beta of 1.40, watch earnings and PFAS news | High beta means CC amplifies market moves. PFAS litigation headlines can cause sudden price gaps. |
| Invalidation | Close below $15, then below $10 | A close below $15 weakens the recovery setup. A break below the $10.44 low would invalidate the turnaround trend. |
CC AI trading strategy
The CC AI trading strategy below is a rules-based framework, not personal advice. It connects price behavior with chemical market conditions, PFAS litigation developments, free cash flow generation, and debt management progress.
Look for CC to break above $20 with above-average volume while the company reports positive free cash flow, manageable PFAS settlement updates, and stable TiO2 pricing.
A failed breakout followed by a close below $15 should reduce trend confidence, especially if PFAS costs escalate or chemical demand weakens.
If CC pulls back toward the $12 to $15 range on PFAS headline fear but without fundamental liquidity stress, compare the lower price with book value, cash position, and normalized earnings power.
Do not treat a lower price as attractive if the company is burning cash, approaching debt covenants, or facing an unquantified litigation liability.
Track quarterly revenue mix, TiO2 utilization rates, Opteon refrigerant adoption, PFAS settlement progress and timing, free cash flow, debt levels, interest coverage, and net debt-to-EBITDA ratio.
Position sizing should reflect that CC is a highly leveraged cyclical chemical company with litigation exposure, where capital structure risk is as important as operational risk.
Investment research summary
Customers pay Chemours for TiO2 pigments that make paint white and opaque, for refrigerants that cool buildings and vehicles, and for specialty chemicals that enable electronics, semiconductors, energy systems, and industrial processes under trusted brands like Teflon, Nafion, and Opteon.
The moat is strongest in fluoropolymer and refrigerant IP where Chemours holds proprietary technology and brand recognition. The Nafion membrane business has strong positioning in electrochemical and hydrogen applications. TiO2 is a commodity with limited differentiation.
The thesis fails if PFAS liabilities exceed current estimates and absorb free cash flow for years, if TiO2 demand falls in a global recession, if refrigerant regulations shift faster than expected, if debt covenants restrict operations, or if the company needs dilutive equity financing.
Management has been focused on improving operational efficiency, reducing debt, resolving PFAS litigation, and stabilizing earnings. The quality assessment depends on whether they can navigate the PFAS liability overhang while maintaining adequate liquidity for the cyclical chemical business.
Chemours benefits from structural demand for refrigerants (Opteon adoption), fluoropolymers for electronics and EVs, TiO2 for construction and coatings, and specialty chemicals for clean energy (Nafion for hydrogen and chlor-alkali). The downside is cyclical end-market exposure and regulatory pressure on PFAS chemistries.
At $17.81, CC trades at 0.46x sales and 12.15x forward earnings estimates. The EV/EBITDA of 21.40x is high for a chemical company, reflecting the debt burden. Margin of safety depends on whether earnings can recover to a level that supports the capital structure without dilution or restructuring.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CC quote reference | $17.81 closing price on July 10, 2026 | Yahoo Finance CC summary | July 13, 2026 |
| Market capitalization verification | $2.678 billion reported, $2.678 billion calculated from $17.81 x 150.4 million shares | Pineify financial_rigor.py and Yahoo Finance CC statistics | July 13, 2026 |
| Shares outstanding | Approximately 150.4 million shares outstanding | Yahoo Finance CC statistics | July 13, 2026 |
| TTM revenue | $5.82 billion trailing twelve months revenue | Yahoo Finance CC statistics | July 13, 2026 |
| TTM net income and EPS | -$410 million net income and -$2.73 diluted EPS | Yahoo Finance CC statistics | July 13, 2026 |
| Q1 2026 earnings | $1.38 billion revenue, $8 million net income, showing early turnaround | Yahoo Finance CC income statement | July 13, 2026 |
| Balance sheet | $563 million cash, total debt/equity 2,033.80%, enterprise value $6.51 billion | Yahoo Finance CC statistics | July 13, 2026 |
| Cash flow | $216.25 million levered free cash flow (ttm) | Yahoo Finance CC statistics | July 13, 2026 |
| Valuation ratios | 0.46x price-to-sales, 12.15x forward PE, 12.46x price-to-book, 1.12x EV/Revenue, 21.40x EV/EBITDA | Yahoo Finance CC statistics | July 13, 2026 |
| 52-week range | $10.44 to $28.67 with beta of 1.40 | Yahoo Finance CC summary | July 13, 2026 |
| Dividend | $0.35 annual dividend, 2.01% forward yield | Yahoo Finance CC summary | July 13, 2026 |
| Analyst consensus | 1-year price target $25.33, Mizuho Outperform with $25 target, JPMorgan raised view | Yahoo Finance CC analysts and recent news | July 13, 2026 |
| PFAS settlement | $450 million federal PFAS settlement with ongoing state litigation including NY lawsuit | Yahoo Finance CC news and CBS News | July 13, 2026 |
This CC AI stock analysis is an informational research tool only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast scenarios are based on available filings, market data, and assumptions as of the stated cutoff date and may be wrong. The Chemours Company faces material PFAS litigation, high debt leverage, and cyclical chemical market risks that make forward projections highly uncertain.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
